Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 82 of 1714:
72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type X, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type IX, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage gated, type VIII, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type VII, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type IV, beta ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type IV, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type III, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type II, beta ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type II, alpha 2 ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type I, beta ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type I, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
nuclear receptor subfamily 3, group C, member 1 BETA-ESTRADIOL Glucocorticoid 61% 41.422uM 18.828uM View
A3 adenosine receptor CELECOXIB Adenosine A3 61% 24.622uM 13.917uM View
5-hydroxytryptamine (serotonin) receptor 2B ALPHA-NAPHTHOFLAVONE Serotonin 5-HT2B 61% NoneNone NoneNone View
androgen receptor DEXAMETHASONE Testosterone 61% 24.556uM 16.371uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 3-METHYLCHOLANTHRENE Adrenergic, Norepinephrine Transporter 61% 29.65uM 29.405uM View
lymphocyte protein tyrosine kinase (mapped) DOXORUBICIN Protein Tyrosine Kinase, Lck 61% 31.913uM NoneNone View
nitric oxide synthase 3 (endothelial cell) 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Nitric Oxide Synthase, Constitutive (cNOS) 61% NoneNone NoneNone View
nitric oxide synthase 3, endothelial cell 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Nitric Oxide Synthase, Constitutive (cNOS) 61% NoneNone NoneNone View
melanocortin 5 receptor PACLITAXEL Melanocortin MC5 61% 17.133uM 16.072uM View
5-hydroxytryptamine (serotonin) receptor 3a AMLODIPINE Serotonin 5-HT3 61% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3b AMLODIPINE Serotonin 5-HT3 61% NoneNone NoneNone View
opioid receptor, delta 1 CHLORPROMAZINE Opiate delta 61% 20.894uM 7.365uM View
histamine receptor H 2 AMIODARONE Histamine H2 61% 10.555uM 10.379uM View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 NIFEDIPINE Adenosine Transporter 61% 23.832uM 8.153uM View
concentrative Na+ nucleoside cotransporter (DBSS) NIFEDIPINE Adenosine Transporter 61% 23.832uM 8.153uM View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 NIFEDIPINE Adenosine Transporter 61% 23.832uM 8.153uM View
adenine nucleotide translocase (DBSS) (Non-specific probe) NIFEDIPINE Adenosine Transporter 61% 23.832uM 8.153uM View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 NIFEDIPINE Adenosine Transporter 61% 23.832uM 8.153uM View
calcium channel, voltage-dependent, gamma subunit 7 CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit GUANABENZ Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit GUANABENZ Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit GUANABENZ Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit GUANABENZ Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit GUANABENZ Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
estrogen receptor 1 MIFEPRISTONE Estrogen ERalpha 61% 23.638uM 6.754uM View
estrogen receptor 1 MIFEPRISTONE Estrogen ERalpha 61% 23.638uM 6.754uM View
nuclear receptor subfamily 3, group C, member 1 DIETHYLSTILBESTROL Glucocorticoid 61% 10.6uM 4.818uM View
sodium channel, voltage-gated, type IV, beta ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel associated protein 1 ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel associated protein 2 ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type III, beta ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 ZAFIRLUKAST CYP450-3A4 Inhibition 61% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase ACLARUBICIN CYP450-1A2 Inhibition 61% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A MONTELUKAST Serotonin 5-HT1A 61% NoneNone NoneNone View
melanocortin 5 receptor FLUNARIZINE Melanocortin MC5 61% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) RIFAPENTINE CYP450-2C9 Inhibition 61% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 RIFAPENTINE CYP450-2C9 Inhibition 61% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) TENOXICAM CYP450-2C9 Inhibition 61% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 TENOXICAM CYP450-2C9 Inhibition 61% NoneNone NoneNone View
A3 adenosine receptor ACLARUBICIN Adenosine A3 61% NoneNone NoneNone View
adrenergic receptor, alpha 1a BERBERINE CHLORIDE Adrenergic alpha1A 61% NoneNone NoneNone View
adrenergic receptor, alpha 1b BERBERINE CHLORIDE Adrenergic alpha1B 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 IVERMECTIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
adrenergic receptor, alpha 2a MAPROTILINE Imidazoline I2, Central 61% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) MAPROTILINE Imidazoline I2, Central 61% NoneNone NoneNone View
adrenergic receptor, alpha 1a DESLORATADINE Adrenergic alpha1A 61% NoneNone NoneNone View
cholinergic receptor, muscarinic 3 QUETIAPINE Muscarinic M3 61% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 PYRILAMINE Muscarinic M5 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 NITRENDIPINE Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 NITRENDIPINE Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 NITRENDIPINE Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 NITRENDIPINE Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 NITRENDIPINE Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 NITRENDIPINE Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 NITRENDIPINE Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 NITRENDIPINE Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit NITRENDIPINE Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit NITRENDIPINE Calcium Channel Type L, Phenylalkylamine 61% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) DIPHENHYDRAMINE Imidazoline I2, Central 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 HALOPROGIN Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 CISAPRIDE Calcium Channel Type L, Dihydropyridine 61% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A CLEMASTINE Serotonin 5-HT1A 61% NoneNone NoneNone View
dopamine receptor D1A THIMEROSAL Dopamine D1 61% NoneNone NoneNone View
melanocortin 3 receptor BENZOTHIAZYL DISULFIDE Melanocortin MC3 61% NoneNone NoneNone View
melanocortin 3 receptor BENZOTHIAZYL DISULFIDE Melanocortin MC3 61% NoneNone NoneNone View
androgen receptor DESOXIMETASONE Testosterone 61% NoneNone NoneNone View
melanocortin 5 receptor FLUPHENAZINE Melanocortin MC5 61% 9.518uM 8.929uM View
epidermal growth factor receptor S(-)-CARBIDOPA Protein Tyrosine Kinase, EGF Receptor 61% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A TOLNAFTATE Serotonin 5-HT2A 61% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 HALOPERIDOL Dopamine Transporter 61% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 GENTIAN VIOLET Adrenergic, Norepinephrine Transporter 61% NoneNone NoneNone View
adrenergic receptor, alpha 2b MOSAPRIDE Adrenergic alpha2C 61% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) MOSAPRIDE Adrenergic alpha2C 61% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 CITALOPRAM Muscarinic M5 61% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 RWJ-68354 Dopamine Transporter 61% NoneNone NoneNone View
thromboxane A synthase 1 RWJ-68354 Thromboxane Synthetase 61% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) RWJ-68354 Thromboxane Synthetase 61% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) RWJ-68354 Adrenergic alpha1D 61% NoneNone NoneNone View
adrenergic receptor, alpha 2a IRINOTECAN Imidazoline I2, Central 61% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) IRINOTECAN Imidazoline I2, Central 61% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 NABUMETONE Dopamine Transporter 61% NoneNone NoneNone View
adrenergic receptor, alpha 2a KETOTIFEN Imidazoline I2, Central 61% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) KETOTIFEN Imidazoline I2, Central 61% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 BOPINDOLOL Serotonin Transporter 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit OXYBUTYNIN Calcium Channel Type L, Benzothiazepine 61% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 4 polypeptide OXICONAZOLE ATPase, Na+/K+ 61% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide OXICONAZOLE ATPase, Na+/K+ 61% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide OXICONAZOLE ATPase, Na+/K+ 61% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide OXICONAZOLE ATPase, Na+/K+ 61% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 1 polypeptide OXICONAZOLE ATPase, Na+/K+ 61% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide OXICONAZOLE ATPase, Na+/K+ 61% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide OXICONAZOLE ATPase, Na+/K+ 61% NoneNone NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide OXICONAZOLE ATPase, Na+/K+ 61% NoneNone NoneNone View
mu-opioid receptor MOR OXICONAZOLE Opiate mu 61% NoneNone NoneNone View
dopamine receptor D3 CETYLPYRIDINIUM BROMIDE Dopamine D3 61% NoneNone NoneNone View
adrenergic receptor, alpha 2a DAPIPRAZOLE Imidazoline I2, Central 61% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) DAPIPRAZOLE Imidazoline I2, Central 61% NoneNone NoneNone View
opioid receptor, sigma 1 BENZETHONIUM CHLORIDE Sigma1 61% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type I, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type IX, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type VII, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
amiloride-sensitive cation channel 5, intestinal ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type III, beta ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type XI, alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type I, beta ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type 10, alpha polypeptide ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type IV, alpha polypeptide ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type V, alpha polypeptide ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, voltage-gated, type II, beta ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, nonvoltage-gated 1 alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, nonvoltage-gated 1 gamma ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View